


Healthcare Industry News: HIV/AIDS
News Release - December 1, 2015
Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For SB-FIX, First In Vivo Protein Replacement Platform Program For Treatment Of Hemophilia B
Source: Sangamo BioSciences
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
